At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global ...

Cytek Biosciences has recurring revenue growth, improving margins, and ample cash that should continue compounding shareholder value over time. See why CTKB is a Buy.

ACS--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced that Chief Medical Officer ...

An update from bioAffinity Technologies, Inc. ( ($BIAF) ) is now available. On December 3, 2025, bioAffinity Technologies announced that it will ...

This study retrospectively analyzed ten pediatric patients with HOX-driven AML who received revumenib maintenance after HSCT at a single-center. The median age was 10 years (range: 1-18). 80% (8/10) ...

TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed AML patients with diverse mutations; Safety continues to b ...

Earlier this month, Cytek Biosciences reported third quarter results, posting revenue of US$52.29 million and a net loss of US$5.48 million, as well as reaffirming its full-year 2025 revenue guidance.

People come to Orlando to escape. With Disney World, SeaWorld and Universal Studios all in the area, there are endless ...

Study met its primary endpoint demonstrating that GRI-0621 was well tolerated over 12 weeks of treatment, with no drug-related severe or serious ...

Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...